Afuco™ Anti-Human PRG3 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-PRG3 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibody is capable of binding to the PRG-3 protein, and uses as a pharmaceutical composition, cell growth inhibitor, and an anticancer agent. Examples of the type of cancer include hepatocellular carcinoma, lung cancer, colon cancer, and glioblastoma.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-708CL |
| Pricing | Inquiry |
| Type | ADCC enhanced antibody |
| Storage | ≤1 year at -20°C. |
| Target | PRG3 |
| Species Reactivity | Human |